News

Article

Evonik Launches Advanced Combination Polymer for Enteric Coatings

An advanced combination polymer for enteric coatings has been launched by Evonik and will be showcased during AAPS PharmSci 360 in Washington D.C.

Specialty chemicals company Evonik has launched an advanced combination polymer for enteric coatings, Eudragit FL 30 D-55, which leverages the company’s new advanced excipient manufacturing process (AEMP) technology.

The combination polymer is suitable for the compression of coated multiparticulates due to its flexibility that enables plasticizer-free formulations. The company reports that the spray suspension preparation times can be reduced by 70%. Additionally, it has been shown to reduce film thickness, meaning that there is a possibility for increased drug loading with multiparticulates.

"As the first ever excipient based upon our proprietary AEMP technology, Eudragit FL 30 D-55 combines the best features of two well-accepted polymers including Eudragit L 30 D-55, which has been the gold standard for enteric coatings for decades," said Paul Spencer, global head of Oral Drug Delivery Solutions for the Health Care business line of Evonik in a press release. "This high-tech excipient features extremely high flexibility even without plasticizers. Eudragit FL 30 D-55 sets a new standard for enteric coatings to help customers reduce processing complexity, lower preparation times, and save costs."

Visitors to AAPS PharmSci 360, taking place in Washington DC from Nov. 4–7, 2018, can find out more about this product at booth 9K20.

Source: Evonik

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content